Importantly, MCT1 is upregulated to activate the LKB1/AMPK signaling pathway and subsequently initiates protective autophagy in OSI-treated CRC cells, conferring resistance to OSI. The gene discussed is PRKAA2; the disease is colorectal carcinoma.